Mentor Capital, Inc. (MNTR) is a public operating company that invests in its larger pre-IPO related acquisitions and fundings. Mentor takes a significant position in the various members of our family of participating companies but leaves operating control in the hands of founders and owners. This allows founders to continue to lead and grow their businesses with the funding, acquisition currency, and benefits of working within the public environment. Investors also may find liquidity if they choose to exchange all or part of their ownership for Mentor shares.
In late 2019, Mentor Capital expanded its target industry from its primary focus on medical marijuana and cannabis companies to potentially include energy, mining and minerals, technology, consumer products, management services, and manufacturing sectors with the goal of ensuring increased market opportunities and investment diversification.
Mentor seeks to deliver a higher price to founders for a smaller slice of their business. Retaining control, receiving greater liquidity, and working with a square corner organization are three key advantages for founders working with Mentor Capital, Inc.
In August 2013, Mentor Capital migrated to the cannabis space from leading-edge cancer investments when government actions collapsed the new leading cancer sector (e.g., Dendreon, a $5 billion market leader, dropped from $44 per share to $1.60 per share before filing for bankruptcy.) Similarly, in late 2019, in response to the approximate 60% decline in the cannabis market, Mentor Capital, Inc. chose to expand its investment focus. Because adult social use and medical marijuana opportunities often overlapped, Mentor Capital participated in the ancillary legal recreational cannabis market. However, Mentor's preferred focus was medical, and the company sought to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson's disease, reducing intraocular pressures from glaucoma and blunting chronic pain. Mentor has liquidated its cancer legacy assets and has applied those sale proceeds to pre-IPO cannabis companies. Mentor has remaining legacy assets in the cannabis space and a remaining legacy asset in Waste Consolidators, Inc. (WCI), which began in 2003 and was a $72,000 position. Today, WCI has grown to over $4.8M in sales annually.
Originally, Mentor Capital was formed in Silicon Valley in 1985 with $1,000 by the current CEO, Chet Billingsley. The company completed dozens of early private acquisitions and went public in 1996.
Mentor Capital feels there is an opportunity to approach pre-IPO companies as a business-focused, high-integrity, public company providing significantly more financing to private companies. As a result, Mentor will be able to return increasing stock value to the investing public.
Leaders in the energy, mining and minerals, technology, consumer products, management services, and manufacturing sectors who are seeking the advantages of the public market, including greater ease of funding, liquidity, a pathway for investor exit, plus the availability of acquisition currency are encouraged to contact Mentor Capital to discuss how they might capture those public benefits by working through MNTR.